These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 11255658)
1. [Low turnover renal osteodystrophy--current state and perspectives]. Nowak Z Pol Merkur Lekarski; 2000 Dec; 9(54):869-72. PubMed ID: 11255658 [TBL] [Abstract][Full Text] [Related]
2. [Renal osteodystrophy in dialysis patients as estimated by three-point bone densitometry]. Kucharska E; Stompór T; Sułowicz W; Drozdz M; Kaczmarczyk I; Szymczakiewicz-Multanowska A; Chruściel B; Kraśnicka M Przegl Lek; 2000; 57(6):334-9. PubMed ID: 11107868 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for renal osteodystrophy: a multivariant analysis. Pei Y; Hercz G; Greenwood C; Segre G; Manuel A; Saiphoo C; Fenton S; Sherrard D J Bone Miner Res; 1995 Jan; 10(1):149-56. PubMed ID: 7747622 [TBL] [Abstract][Full Text] [Related]
4. Vitamin D therapy in CAPD: what is its role? Hutchison AJ; Gokal R Adv Perit Dial; 1993; 9():253-6. PubMed ID: 8105937 [TBL] [Abstract][Full Text] [Related]
7. Features of renal osteodystrophy in pediatric patients receiving regular peritoneal dialysis. Salusky IB; Brill J; Oppenheim W; Goodman WG Semin Nephrol; 1989 Mar; 9(1):37-42. PubMed ID: 2740652 [No Abstract] [Full Text] [Related]
8. The spectrum of renal osteodystrophy in peritoneal dialysis patients. Delmez JA Perit Dial Int; 1996; 16(1):24-5. PubMed ID: 8616168 [No Abstract] [Full Text] [Related]
9. Bone disease in moderate renal failure: cause, nature and prevention. Bushinsky DA Annu Rev Med; 1997; 48():167-76. PubMed ID: 9046953 [TBL] [Abstract][Full Text] [Related]
10. [Bone turnover markers in diabetics treated with continuous ambulatory peritoneal dialysis]. Nowak Z; Konieczna M; Wańkowicz Z Pol Arch Med Wewn; 1999 Jul; 102(1):575-81. PubMed ID: 10835918 [TBL] [Abstract][Full Text] [Related]
11. [Letter to the authors of the "Recommendations for clinical practice" concerning the prevention of renal osteodystrophy before extra-renal purification]. Fournier A; Aparicio M Nephrologie; 1998; 19(3):129-30. PubMed ID: 9633056 [No Abstract] [Full Text] [Related]
13. Deferoxamine for the diagnosis and treatment of aluminum-associated osteodystrophy. Charhon S; el Yafi S; Gaillard M; Beruard M; Janin G; Accominotti M; Traeger J; Meunier PJ Contrib Nephrol; 1988; 64():160-9. PubMed ID: 3180823 [No Abstract] [Full Text] [Related]
18. [Bone and joint complications in patients treated with continuous ambulatory peritoneal dialysis (CAPD) for more than 3 years]. Dratwa M; Wens R; Collart F; Tielemans C Nephrologie; 1989; 10 Suppl():56-61. PubMed ID: 2812191 [TBL] [Abstract][Full Text] [Related]
19. [Pathophysiology and treatment of renal osteodystrophy]. Ionova D Vutr Boles; 1985; 24(6):23-9. PubMed ID: 3913143 [No Abstract] [Full Text] [Related]